UCLH Brain Tumour Service awarded ‘Tessa Jowell Centre of Excellence Status’
03 March 2021
Publish date: 18 January 2021
On 1 December the High Court ruled that children and young people may not be able to consent to puberty-blocking treatment in cases of gender dysphoria. Read more.
The Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS), has today (18 January) been granted permission by the court to appeal against the ruling.
Endocrinologists at UCLH and Leeds Teaching Hospitals NHS Trust prescribe and administer puberty-blocking drugs on behalf on the Tavistock’s GID service.
Our statement in response to the court’s decision today is as follows:
A UCLH spokesperson said: “We welcome the court’s decision to allow the Tavistock and Portman to appeal against the ruling. Our priority is to work with the Tavistock to support our patients and their families while legal proceedings are ongoing.”
For accurate and up-to-date information about the ruling and the appeal visit the GIDS website: www.gids.nhs.uk
If you are a UCLH patient or parent who would like to speak to a member of our clinical team please call 07812 512 126. This number is for patients and their families only.
Journalists should email email@example.com. This email address is for members of the media only.